search

Active clinical trials for "Lung Neoplasms"

Results 1651-1660 of 6521

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer...

Lung Neoplasm

Create a living biobank of PDOs from Stage I-III lung cancer patients.

Recruiting6 enrollment criteria

Fluid Biopsy for the Diagnosis of Lung Cancer

Lung Carcinoma

This trial collects and studies blood samples via fluid biopsy for the diagnosis of lung cancer. Studying blood samples in the laboratory may help doctors develop a blood test for lung cancer in the future and provide a better way to screen patients for lung cancer.

Recruiting6 enrollment criteria

Imaging-based Deep Learning for Lung Cancer Diagnosis and Staging

Lung Cancer

Lung cancer diagnosis and staging are two fundamental and critical issue in clinical lung cancer management and therapeutic decision-making. Invasive procedures for pathologic analysis are gold standard for diagnosis and staging, however, invasive procedures related-complications are inevitable. Noninvasive medical imaging is a powerful tool, however there is almost no room for improvement just according to the experience of radiologist and clinician. The researchers will investigate the role of computer based deep learning of medical imaging in the diagnosis of lesion of lung, lymph node and other sites suspected with metastasis.

Recruiting3 enrollment criteria

Biomarkers for Risk Stratification in Lung Cancer

Nodule Solitary PulmonaryNon-small Cell Lung Cancer

This is a prospective observational study that will follow patients who undergo lung cancer screening at the San Francisco VA Medical Center, University of California, San Francisco (UCSF) Medical Center, and the San Francisco General Hospital. The proposed study will comprise of two primary populations to determine the ctDNA assay performance in a variety of clinical settings.

Recruiting10 enrollment criteria

A Prospective Cohort Study of Chinese Patients With Pulmonary Nodules: Prediction of Lung Cancer...

Pulmonary Nodules

The broad goals of this study is to identify changes in genomic landscape during transition from stage 0 to stage 1 lung cancer. This study intends to determine whether diagnostic biomarkers measured in minimally invasive biospecimens are able to correlate molecular, clinical and imaging features to distinguish malignant from benign pulmonary nodules. The diagnostic markers once validated can be used as broad screening tools for lung cancer.

Recruiting14 enrollment criteria

Assessment of Early-detection Based on Liquid Biopsy in Lung Cancer (ASCEND-LUNG)

Lung Cancer

The purpose of this study is to develop a lung cancer diagnosis tool using a multi-omics approach based on liquid biopsy.

Recruiting15 enrollment criteria

Heterogeneity of Dendritic Cells in Colon and Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Prospective study with the use of biological samples. The centers involved are the Thoracic Surgery and Surgery 1 Units of the San Gerardo Hospital in Monza.

Recruiting8 enrollment criteria

Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive...

Lung Cancer

This is a longitudinal, consecutive case-series, multi-center study with mixed prospective and retrospective data collection. Data will be collected from eligible adults with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC) treated with dacomitinib as first-line therapy from the date of advanced NSCLC diagnosis to the date of death, lost to follow-up, withdrawal of consent or end of study, whichever occurs first.

Recruiting4 enrollment criteria

Immune Checkpoints in COPD

Lung CancerSevere ARDS2 more

The aim of this study is to investigate the mechanisms underlying the complex interaction between Chronic obstructive pulmonary disease (COPD) and lung cancer. Therefore, in order to identify a possible role of immune checkpoints not only in the susceptibility to COPD development but also in its evolution towards lung cancer, will be evaluate the correlation between PD-L1 expression and cigarette smoke exposure in COPD patients. Although there are many epidemiological studies highlighting the interconnections between COPD and lung cancer and the influence of cigarette smoke, the molecular bases of this association are less well defined. Initially they were thought to be driven just by innate inflammation, however, recent studies have also demonstrated the influence of the adaptive immune system. Despite this, the role of immune checkpoints in chronic lung inflammatory diseases such as COPD is less well understood. COPD is currently the 4th leading cause of death worldwide but is assessed to be the 3rd by the end of 2020 resulting in an economic and social burden that is in continuous progression.

Recruiting12 enrollment criteria

Neoadjuvant Immune Checkpoint Inhibitor Combined With Chemotherapy in Non-small Cell Lung Cancer...

Non-small Cell Lung Cancer

The primary object of this study is to determine tumor major pathological response (MPR) rate and pathologic complete response (pCR) rate in stage IB-IIIA non-small cell lung cancer who subjected to neoadjuvant immune checkpoint inhibitor combined with chemotherapy and molecular biomarkers related to the clinical response.

Recruiting14 enrollment criteria
1...165166167...653

Need Help? Contact our team!


We'll reach out to this number within 24 hrs